Chimeric Mouse Model with
Highly Humanized Liver
Highly Humanized Liver
KMT Hepatech, Inc. is a part of PhoenixBio group since December 1, 2017
KMT Hepatech is a production facility of PhoenixBio Group products (PXB-mouse® and PXB-cells®) in North America.
PhoenixBio Group is utilizing its proprietary platform technology of small animal model of chimeric mouse with highly humanized liver, the PXB-mouse®.
The PXB-mouse® and PXB-cells® are your essential tools for therapeutics and vaccine development.
Commercial scale production of high quality chimeric mice
Always available for shipment
Stable engraftment for entire lifespan
Long-term applications – over 30 days in study
On-demand supply with consistent donor for in vitro reproducibility
Compatible with your preferred format including 3D
News and Events
Digital Communication in Science and Business – Is It “New Normal”?
During last two months many of us saw their colleagues only via such applications as Zoom, WebEx, Google Hangouts and other video conferencing systems. With conferences and workshops going virtual,…
Species differences in liver accumulation and metabolism
Species differences in liver accumulation and metabolism of nucleotide prodrug are discussed in the April 2020 publication by Gilead team. The difficulty in projecting human dose based on preclinical data…
COVID-19 Update from PhoenixBio Group
PhoenixBio’s Response to COVID19 Dear Valued Customers, Collaborators and Partners, We are writing this letter to ensure you that the PhoenixBio Group continues to operate at full capacity and is…
Poster Presentations Planned for the SOT 59th Annual Meeting
PhoenixBio at 2020SOT PhoenixBio poster presentations and booth exhibition sponsorship were planned for the SOT 59th Annual Meeting and ToxExpo from March 15th – March 19th, 2020 in Anaheim, California,…
A new publication on lipoprotein profile and lipid metabolism of PXB-cells®
PXB-cells® – Human Primary Hepatocytes for screening anti-lipidemic drugs We are happy to share our Study Team’s recent work on the use of PXB-cells for in vitro anti-lipidemic drug screening:…
Meet us at Keystone Symposia in Banff, February 23-27!
Obesity and NAFLD: Mechanisms and Therapeutics Don’t miss our NASH Poster “Development of humanized NASH liver model using chimeric mice with highly repopulated humanized livers” presented by Dr. Svetlana Sapelnikova…